About
Technology
Issues
FAQ
Search
Profile
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Main Topics
Most Cited Articles
Scientometrics
Avg Impact Factor
★★
Articles
★★★
Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Schools
›
Centre for Rheumatology and Connective Tissue Diseases
›
top-articles
Centre for Rheumatology and Connective Tissue Diseases
20
(top 2%)
papers
593
(top 2%)
citations
10
(top 2%)
h
-index
18
(top 2%)
g
-index
24
all documents
657
doc citations
316
citing journals
Top Articles
#
Title
Journal
Year
Citations
1
Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosis
Thorax
2013
193
2
Connective tissue growth factor: growth factor, matricellular organizer, fibrotic biomarker or molecular target for anti-fibrotic therapy in SSc?
Rheumatology
2008
70
3
Endothelin--role in vascular disease
Rheumatology
2008
63
4
Endothelin in Pulmonary Fibrosis
American Journal of Respiratory Cell and Molecular Biology
2011
62
5
Sustained benefit from intravenous immunoglobulin therapy for gastrointestinal involvement in systemic sclerosis
Rheumatology
2016
62
6
Changes in macrophage transcriptome associate with systemic sclerosis and mediate
GSDMA
contribution to disease risk
Annals of the Rheumatic Diseases
2018
60
7
Endothelial C-Type Natriuretic Peptide Is a Critical Regulator of Angiogenesis and Vascular Remodeling
Circulation
2019
58
8
Macrophage Epoxygenase Determines a Profibrotic Transcriptome Signature
Journal of Immunology
2015
28
9
Distinctive clinical phenotype of anti-centromere antibody-positive diffuse systemic sclerosis
Rheumatology Advances in Practice
2018
15
10
Scleroderma Lung Involvement, Autoantibodies, and Outcome Prediction: The Confounding Effect of Time
Journal of Rheumatology
2017
14
11
Interaction between the promoter MUC5B polymorphism and mucin expression: is there a difference according to ILD subtype?
Thorax
2020
8
12
Outcomes linked to eligibility for stem cell transplantation trials in diffuse cutaneous systemic sclerosis
Rheumatology
2022
6
13
Challenges in physician-patient communication for optimal management of systemic sclerosis-associated interstitial lung disease: a discourse analysis
Clinical Rheumatology
2020
4
14
Scleroderma Renal Crisis
Clinical Rheumatology
2012
3
15
Things left unsaid: important topics that are not discussed between patients with systemic sclerosis, their carers and their healthcare professionals—a discourse analysis
Clinical Rheumatology
2021
3
16
Saphenous Vein Vasa Vasorum as a Potential Target for Perivascular Fat-Derived Factors
Brazilian Journal of Cardiovascular Surgery
2020
3
17
TGF-β and smad signalling in fibrosis
Experimental Dermatology
2008
2
18
A Brief Comment on Vasa Vasorum of Human Saphenous Vein: relevance for Coronary Artery Bypass Surgery
Brazilian Journal of Cardiovascular Surgery
2021
1
19
Overview of Gastrointestinal Tract Involvement
Brazilian Journal of Cardiovascular Surgery
2017
1
20
Three Cases of Systemic Sclerosis Within One Family With Different Antibodies and Clinical Features
Journal of Rheumatology
2022
1
21
O40 Expression and Function of the P2X7 Receptor in Dermal Fibroblasts from Patients with Systemic Sclerosis
Rheumatology
0
0
22
SAT0232 Anti-Centromere Antibody Positive Diffuse Scleroderma Is Uncommon but Has A Distinct Clinical Phenotype
Annals of the Rheumatic Diseases
2016
0
23
SAT0334 Correlating muliplex plasma cytokine analysis with right heart catheterisation findings in scleroderma associated pulmonary arterial hypertension
Annals of the Rheumatic Diseases
2017
0
site/software ©
exaly
; All materials licenced under
CC by-SA
.